Home ETF List About

ETF Holdings Breakdown of BIIB

Stock NameBiogen Inc
TickerBIIB(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS09062X1037
LEIW8J5WZB5IY3K0NDQT671

BIIB institutional holdings

The following institutional investment holdings of BIIB have been identified

Date ETF ISIN/Name Num Shares Book value
2025-09-18 IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc)) 343,304 0.0%USD 49,370,548 -0.7%
2025-09-18 IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist)) 343,304 0.0%USD 49,370,548 -0.7%
2025-09-18 IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)) 343,304 0.0%USD 49,370,548 -0.7%
2025-09-18 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 210,167 0.1%USD 30,224,116 -0.6%
2025-09-18 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 210,167 0.1%USD 30,224,116 -0.6%
2025-09-18 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 210,167 0.1%USD 30,224,116 -0.6%
2025-09-18 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 210,167 0.1%USD 30,224,116 -0.6%
2025-09-18 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 15,804 0.4%USD 2,272,773 -0.4%
2025-09-18 IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist)) 52,043 0.0%USD 7,484,304 -0.7%
2025-09-18 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 36,003USD 5,177,591 -0.7%
2025-09-18 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 36,003USD 5,177,591 -0.7%
2025-09-18 IE00B53SZB19 (iShares NASDAQ 100 UCITS ETF USD (Acc)) 177,025 0.2%USD 25,457,965 -0.5%
2025-09-18 IE00BYVQ9F29 (iShares NASDAQ 100 UCITS ETF) 177,025 0.2%USD 25,457,965 -0.5%
2025-09-18 IE00BYX2JD69 (iShares MSCI World SRI UCITS ETF) 81,183USD 11,674,927 -0.7%
2025-09-18 IE00BMZ17T93 (iShares MSCI World SRI UCITS ETF GBP Hedged (Dist) GBP) 81,183USD 11,674,927 -0.7%
2025-09-18 IE00BMZ17X30 (iShares MSCI World SRI UCITS ETF USD Hedged (Dist)) 81,183USD 11,674,927 -0.7%
2025-09-18 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 41,683 0.3%USD 5,994,432 -0.5%
2025-09-18 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 41,683 0.3%USD 5,994,432 -0.5%
2025-09-18 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 41,683 0.3%USD 5,994,432 -0.5%
2025-09-18 IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc)) 123,771 200.0%USD 17,799,508 200.7%
2025-09-18 IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist)) 123,771 200.0%USD 17,799,508 200.7%
2025-09-18 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 14,663USD 2,108,686 -0.7%
2025-09-18 IE00BYVJRR92 (iShares MSCI USA SRI UCITS ETF USD (Acc)) 42,265 -0.1%USD 6,078,130 -0.9%
2025-09-18 IE00BZ173V67 (iShares MSCI USA SRI UCITS ETF EUR Hedged (Dist)) 42,265 -0.1%USD 6,078,130 -0.9%
2025-09-18 IE00BZ173T46 (iShares MSCI USA SRI UCITS ETF USD (Dist)) 42,265 -0.1%USD 6,078,130 -0.9%
2025-09-18 IE00BMWPV470 (iShares MSCI USA SRI UCITS ETF GBP Hedged (Dist)) 42,265 -0.1%USD 6,078,130 -0.9%
2025-09-18 IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc)) 24,310USD 2,968,768 -0.1%
2025-09-18 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 2,997USD 430,999 -0.7%
2025-09-18 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 2,997USD 430,999 -0.7%
2025-09-18 IE00BP3QZB59 (iShares Edge MSCI World Value Factor UCITS ETF) 42,645USD 6,132,777 -0.7%
2025-09-18 IE00BFYTYS33 (iShares Edge MSCI World Value Factor UCITS USD Dist) 42,645USD 6,132,777 -0.7%
2025-09-18 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 10,456 -0.6%USD 1,503,677 -1.4%
2025-09-18 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 10,456 -0.6%USD 1,503,677 -1.4%
2025-09-18 IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)) 65,458 0.1%USD 9,413,515 -0.6%
2025-09-18 IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc)) 65,458 0.1%USD 9,413,515 -0.6%
2025-09-18 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 9,131USD 1,115,089 -0.1%
2025-09-18 IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) 69,451 0.1%USD 9,987,748 -0.6%
2025-09-18 IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF) 69,451 0.1%USD 9,987,748 -0.6%
2025-09-18 IE00BD1F4M44 (iShares Edge MSCI USA Value Factor UCITS ETF USD (Acc) GBP) 33,617USD 4,834,461 -0.7%
2025-09-18 IE00BFF5RX68 (iShares Edge MSCI USA Value Factor UCITS ETF USD (Dist)) 33,617USD 4,834,461 -0.7%
2025-09-18 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 5,507USD 791,962 -0.7%
2025-09-18 IE00B57X3V84 (iShares Dow Jones Global Sustainability Screened UCITS ETF USD (Acc)) 11,416USD 1,641,735 -0.7%
2025-09-18 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 3,150USD 453,002 -0.7%
2025-09-18 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 111,078USD 15,974,127 -0.7%
2025-09-18 IE0002W8NB38 (iShares MSCI USA Swap UCITS ETF USD (Acc)) 53,993 200.0%USD 7,764,733 200.7%
2025-09-18 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 2,438USD 350,609 -0.7%
2025-09-18 IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc)) 2,438USD 350,609 -0.7%
2025-09-18 IE00BMXC7V63 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD (Acc)) 4,565 0.3%USD 656,493 0.4%
2025-09-18 IE000G4PH2B1 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD Dist) 4,565 0.3%USD 656,493 0.4%
2025-09-18 IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc)) 3,541USD 375,733 0.0%
2025-09-18 IE00B27YCN58 (iShares MSCI World Islamic UCITS ETF USD (Dist) USD) 5,862USD 843,014 -0.7%
2025-09-18 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 86,517 0.3%USD 12,442,010 -0.4%
2025-09-18 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 86,517 0.3%USD 12,442,010 -0.4%
2025-09-18 IE000R9FA4A0 (iShares S&P 500 ESG UCITS ETF USD (Acc)) 2,784USD 400,367 -0.7%
2025-09-18 IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist)) 1,042USD 149,850 -0.7%
2025-09-18 IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc)) 1,042USD 149,850 -0.7%
2025-09-18 IE000OKVTDF7 (iShares MSCI USA Value Factor ESG UCITS ETF USD (Acc)) 3,471USD 499,165 -0.7%
2025-09-18 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 855USD 90,723 0.0%
2025-09-18 IE00BP3QZD73 (iShares MSCI World Mid-Cap Equal Weight UCITS ETF USD (Acc)) 3,269USD 470,115 -0.7%
2025-09-18 IE00BD1F4K20 (iShares MSCI USA Mid-Cap Equal Weight UCITS ETF USD (Acc)) 7,434USD 1,069,084 -0.7%
2025-09-18 IE00B296QM64 (iShares MSCI USA Islamic UCITS) 3,258USD 468,533 -0.7%
2025-09-18 IE00013A2XD6 (iShares MSCI ACWI SRI UCITS ETF USD(Dist)) 836USD 120,225 -0.7%
Total =4,052,613 USD 581,915,249
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with BIIB

Analysts Set Biogen Inc. (NASDAQ:BIIB) PT at $185.74
Shares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have earned a consensus rating of “Hold” from the thirty-two research firms that are currently covering the company, MarketBeat Ratings reports. Twenty-one research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average twelve-month price […] - 2025-09-08 03:08:53
Notable Wednesday Option Activity: WDC, ADBE, BIIB
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Western Digital Corp (Symbol: WDC), where a total volume of 31,773 contracts has been traded thus far today, a contract volume which is representative of approxim - 2025-09-03 14:18:29
Eisai: FDA Approves LEQEMBI IQLIK For Maintenance Dosing In Treatment Of Early Alzheimer's
(RTTNews) - Eisai and Biogen (BIIB) announced that the FDA has approved the Biologics License Application for once weekly lecanemab-irmb subcutaneous injection, or LEQEMBI IQLIK, for maintenance dosing for the treatment of early Alzheimer's. LEQEMBI IQLIK will be launched on Octo - 2025-09-01 03:23:41
Biogen Inc. (NASDAQ:BIIB) Receives $185.63 Consensus PT from Analysts
Biogen Inc. (NASDAQ:BIIB – Get Free Report) has been given a consensus rating of “Hold” by the thirty-two research firms that are covering the stock, MarketBeat Ratings reports. Twenty-one analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The average 1-year price target among brokerages […] - 2025-08-14 03:06:52
Biogen (NASDAQ:BIIB) Price Target Raised to $219.00
Biogen (NASDAQ:BIIB – Free Report) had its price target upped by Royal Bank Of Canada from $208.00 to $219.00 in a research note released on Friday,Benzinga reports. The brokerage currently has an outperform rating on the biotechnology company’s stock. Other equities research analysts have also recently issued research reports about the stock. Canaccord Genuity Group […] - 2025-08-04 06:37:00
Biogen (NASDAQ:BIIB) Given New $194.00 Price Target at HC Wainwright
Biogen (NASDAQ:BIIB – Free Report) had its price objective upped by HC Wainwright from $187.00 to $194.00 in a research report released on Friday,Benzinga reports. HC Wainwright currently has a buy rating on the biotechnology company’s stock. A number of other analysts also recently issued reports on the stock. Mizuho dropped their price target on […] - 2025-08-04 04:35:01
Leerink Partnrs Estimates Biogen’s Q3 Earnings (NASDAQ:BIIB)
Biogen Inc. (NASDAQ:BIIB – Free Report) – Stock analysts at Leerink Partnrs cut their Q3 2025 earnings per share (EPS) estimates for Biogen in a research report issued to clients and investors on Thursday, July 31st. Leerink Partnrs analyst M. Goodman now expects that the biotechnology company will post earnings per share of $3.86 for […] - 2025-08-04 02:46:51
Biogen (NASDAQ:BIIB) Upgraded at Wall Street Zen
Biogen (NASDAQ:BIIB – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Saturday. A number of other equities analysts also recently commented on the stock. Mizuho reduced their target price on shares of Biogen from $207.00 to $169.00 […] - 2025-08-04 02:14:53
Biogen (NASDAQ:BIIB) Stock Acquired Rep. Robert Bresnahan, Jr.
Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of Biogen Inc. (NASDAQ:BIIB). In a filing disclosed on June 09th, the Representative disclosed that they had bought between $1,001 and $15,000 in Biogen stock on May 15th. The trade occurred in the Representative’s “JP MORGAN BROKERAGE ACCOUNT” account. Representative Robert Bresnahan, Jr. also recently made the […] - 2025-08-01 03:02:52
Eisai And Biogen Say Four Years Of Leqembi Helps In Slowing Down Alzheimer's Disease Progression
(RTTNews) - Eisai Co., Ltd. and Biogen Inc. (BIIB) Wednesday said results from Phase 3 Clarity AD study showed that continuous treatment with Leqembi helped in slowing down the progression in patients with early Alzheimer's disease. - 2025-07-30 10:43:06
HighPoint Advisor Group LLC Decreases Stock Holdings in Biogen Inc. (NASDAQ:BIIB)
HighPoint Advisor Group LLC cut its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 10.2% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,736 shares of the biotechnology company’s stock after selling 198 shares during the quarter. HighPoint Advisor Group LLC’s […] - 2025-07-25 05:52:55
Teachers Retirement System of The State of Kentucky Has $1.53 Million Position in Biogen Inc. (NASDAQ:BIIB)
Teachers Retirement System of The State of Kentucky increased its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.8% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,213 shares of the biotechnology company’s stock after purchasing an additional 301 shares during the […] - 2025-07-25 05:05:17
Biogen Inc. (NASDAQ:BIIB) Stake Raised by Victory Capital Management Inc.
Victory Capital Management Inc. boosted its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 4.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 124,756 shares of the biotechnology company’s stock after buying an additional 5,723 shares during the […] - 2025-07-23 07:50:52
Biogen Inc. (NASDAQ:BIIB) Shares Bought by Allworth Financial LP
Allworth Financial LP boosted its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 85.6% in the first quarter, HoldingsChannel.com reports. The fund owned 1,017 shares of the biotechnology company’s stock after purchasing an additional 469 shares during the period. Allworth Financial LP’s holdings in Biogen were worth $139,000 at the end of […] - 2025-07-17 09:58:49
2,500 Shares in Biogen Inc. (NASDAQ:BIIB) Purchased by Alps Advisors Inc.
Alps Advisors Inc. purchased a new position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,500 shares of the biotechnology company’s stock, valued at approximately $342,000. Other institutional investors and hedge funds also […] - 2025-07-17 06:25:03
OneDigital Investment Advisors LLC Makes New $231,000 Investment in Biogen Inc. (NASDAQ:BIIB)
OneDigital Investment Advisors LLC bought a new stake in Biogen Inc. (NASDAQ:BIIB – Free Report) during the 1st quarter, Holdings Channel reports. The firm bought 1,688 shares of the biotechnology company’s stock, valued at approximately $231,000. Several other institutional investors and hedge funds also recently bought and sold shares of BIIB. Lee Danner & Bass […] - 2025-07-14 04:56:54
Amalgamated Bank Increases Stock Position in Biogen Inc. (NASDAQ:BIIB)
Amalgamated Bank increased its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 28,454 shares of the biotechnology company’s stock after purchasing an additional 253 shares during the quarter. Amalgamated Bank’s holdings in Biogen were […] - 2025-07-04 05:24:52
KBC Group NV Purchases 850 Shares of Biogen Inc. (NASDAQ:BIIB)
KBC Group NV raised its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 34,340 shares of the biotechnology company’s stock after purchasing an additional 850 shares during the quarter. KBC Group […] - 2025-07-03 05:36:53
Bessemer Group Inc. Boosts Stake in Biogen Inc. (NASDAQ:BIIB)
Bessemer Group Inc. lifted its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 31.6% in the first quarter, Holdings Channel reports. The firm owned 3,037 shares of the biotechnology company’s stock after acquiring an additional 729 shares during the period. Bessemer Group Inc.’s holdings in Biogen were worth $415,000 as of its most recent […] - 2025-07-02 04:54:54
Golden State Wealth Management LLC Acquires 312 Shares of Biogen Inc. (NASDAQ:BIIB)
Golden State Wealth Management LLC grew its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 117.7% in the first quarter, Holdings Channel reports. The firm owned 577 shares of the biotechnology company’s stock after buying an additional 312 shares during the quarter. Golden State Wealth Management LLC’s holdings in Biogen were worth $79,000 as […] - 2025-07-01 05:13:04
Perpetual Ltd Buys New Shares in Biogen Inc. (NASDAQ:BIIB)
Perpetual Ltd bought a new stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 1,797 shares of the biotechnology company’s stock, valued at approximately $246,000. Other large investors have also recently bought and sold shares of the […] - 2025-06-30 05:10:53
Biogen Inc. (NASDAQ:BIIB) Shares Bought by Chevy Chase Trust Holdings LLC
Chevy Chase Trust Holdings LLC raised its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.4% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 77,115 shares of the biotechnology company’s stock after purchasing an additional 295 shares during the […] - 2025-06-27 06:18:57
Biogen (NASDAQ:BIIB) PT Set at $213.00 by Royal Bank Of Canada
Biogen (NASDAQ:BIIB – Get Free Report) has been assigned a $213.00 target price by equities researchers at Royal Bank Of Canada in a research note issued to investors on Wednesday, MarketBeat.com reports. The firm currently has an “outperform” rating on the biotechnology company’s stock. Royal Bank Of Canada’s target price would indicate a potential upside […] - 2025-06-27 02:28:43
Kentucky Retirement Systems Insurance Trust Fund Sells 4,129 Shares of Biogen Inc. (NASDAQ:BIIB)
Kentucky Retirement Systems Insurance Trust Fund trimmed its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 49.4% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 4,236 shares of the biotechnology company’s stock after selling 4,129 shares during the quarter. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Biogen were […] - 2025-06-25 05:14:55
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Johnson Investment Counsel Inc.
Johnson Investment Counsel Inc. trimmed its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 9.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,513 shares of the biotechnology company’s stock after selling 166 shares during the period. Johnson Investment […] - 2025-06-24 05:06:56
QRG Capital Management Inc. Grows Position in Biogen Inc. (NASDAQ:BIIB)
QRG Capital Management Inc. raised its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 55.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,039 shares of the biotechnology company’s stock after purchasing an additional 1,435 shares […] - 2025-06-22 05:31:04
Fifth Third Bancorp Purchases 2,243 Shares of Biogen Inc. (NASDAQ:BIIB)
Fifth Third Bancorp increased its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 69.1% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 5,489 shares of the biotechnology company’s stock after buying an additional 2,243 shares during the period. Fifth Third Bancorp’s holdings in Biogen were […] - 2025-06-17 04:54:50
CVA Family Office LLC Raises Holdings in Biogen Inc. (NASDAQ:BIIB)
CVA Family Office LLC increased its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 71.1% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 231 shares of the biotechnology company’s stock after acquiring an additional 96 shares during the period. CVA Family Office LLC’s holdings in Biogen […] - 2025-06-16 06:12:43
CX Institutional Takes $180,000 Position in Biogen Inc. (NASDAQ:BIIB)
CX Institutional acquired a new stake in Biogen Inc. (NASDAQ:BIIB – Free Report) in the 1st quarter, Holdings Channel reports. The firm acquired 1,315 shares of the biotechnology company’s stock, valued at approximately $180,000. Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Assenagon Asset Management […] - 2025-06-16 05:14:51
Assenagon Asset Management S.A. Has $6.13 Million Stake in Biogen Inc. (NASDAQ:BIIB)
Assenagon Asset Management S.A. raised its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 3.1% during the first quarter, according to its most recent filing with the SEC. The firm owned 44,796 shares of the biotechnology company’s stock after purchasing an additional 1,336 shares during the period. Assenagon Asset Management S.A.’s holdings in Biogen […] - 2025-06-15 06:54:53

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.